Biopolymer gelatin-coated zinc oxide nanoparticles showed high antibacterial, antibiofilm and anti-angiogenic activity

The use of natural polymers in drug design plays an important role in biomedical applications. Combinations of nanoparticles (NPs) and biopolymers have been shown to be useful for many purposes. This study focused on gelatin-coated zinc oxide NPs synthesized by co-precipitation. The particles were characterized by UV-Vis spectrum, showing a main peak at 375 nm. The stability and crystalline nature of the particles was evaluated by Zeta potential and X-ray diffraction analysis. Fourier transform infrared spectroscopy (FTIR) revealed the possible functional groups of Ge-ZnO NPs, with strong bands at 3851, 3447, and 2923 cm(-1). Moreover, transmission electron microscopy (TEM) highlighted the presence of spherically shaped Ge-ZnO NPs that were 20 nm in size. Energy dispersive analysis X-ray (EDX) analysis showed that the zinc elemental content of Ge-ZnO NPs was 59.10%. The results of antibacterial activity assays revealed higher inhibition of Ge-ZnO NPs against Gram-negative Pseudomonas aeruginosa at 100 mu g/ml over that against Gram-positive Enterococcus faecalis. Greater inhibition of biofilm formation was observed for Gram-negative bacteria compared to Gram-positive bacteria. In addition, Ge-ZnO NPs effectively inhibited the biofilm growth of the fungus Candida albicans at 50 mu g/ml. Ge-ZnO NPs reduced the viability of hepatocarcinoma cancer cell lines at 100 mu g/ml. Moreover, in chick embryos, notable anti-angiogenesis effects were observed for Ge-ZnO NPs and zinc acetate at 50 mu g/ml compared to that observed testing gelatin. Overall, based on the results, Ge-ZnO NPs may be used as a novel agent for the control of biofilm-forming microbial pathogens.